March 29, 2018 / 5:20 PM / a month ago

BRIEF-FDA Expands Approval Of Blincyto

March 29 (Reuters) - The U.S. Food and Drug Administration:

* FDA EXPANDS APPROVAL OF BLINCYTO FOR TREATMENT OF A TYPE OF LEUKEMIA IN PATIENTS WHO HAVE A CERTAIN RISK FACTOR FOR RELAPSE

* SAYS GRANTED APPROVAL OF BLINCYTO TO AMGEN

* SAYS BLINCYTO CARRIES A BOXED WARNING Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below